Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

August 01, 1990; Volume 38,Issue 2
  • You have access
    Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
    U G Klueppelberg, X Molero, R W Barrett and L J Miller
    Molecular Pharmacology August 1990, 38 (2) 159-163;
  • You have access
    Potassium channel blockade by the B subunit of beta-bungarotoxin.
    C G Benishin
    Molecular Pharmacology August 1990, 38 (2) 164-169;
  • You have access
    Interaction of purified bovine brain A1-adenosine receptors with guanine nucleotide-binding proteins of human platelet membranes following reconstitution.
    R Munshi and J Linden
    Molecular Pharmacology August 1990, 38 (2) 170-176;
  • You have access
    Glycoprotein nature of the A2-adenosine receptor binding subunit.
    W W Barrington, K A Jacobson and G L Stiles
    Molecular Pharmacology August 1990, 38 (2) 177-183;
  • You have access
    Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
    Y Kitamura, S Imai, R Matsueda and Y Nomura
    Molecular Pharmacology August 1990, 38 (2) 184-191;
  • You have access
    Growth hormone regulation of the cytochrome P-450IIC subfamily in the rat: inductive, repressive, and transcriptional effects on P-450f (IIC7) and P-450PB1 (IIC6) gene expression.
    S Westin, A Ström, J A Gustafsson and P G Zaphiropoulos
    Molecular Pharmacology August 1990, 38 (2) 192-197;
  • You have access
    Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype.
    F J Rauscher, T A Beerman and R M Baker
    Molecular Pharmacology August 1990, 38 (2) 198-206;
  • You have access
    Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
    S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
    Molecular Pharmacology August 1990, 38 (2) 207-213;
  • You have access
    p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
    M A Gerhardt, S M Wade and R R Neubig
    Molecular Pharmacology August 1990, 38 (2) 214-221;
  • You have access
    Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.
    D D Schoepp, B G Johnson, E C Smith and L A McQuaid
    Molecular Pharmacology August 1990, 38 (2) 222-228;
  • You have access
    Kainate receptors coupled to the evoked release of [3H]-gamma-aminobutyric acid from striatal neurons in primary culture: potentiation by lithium ions.
    S Weiss, D E Kemp, L Bauce and F W Tse
    Molecular Pharmacology August 1990, 38 (2) 229-236;
  • You have access
    2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
    Y Törnevik and S Eriksson
    Molecular Pharmacology August 1990, 38 (2) 237-243;
  • You have access
    Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance.
    T J Resink, T Scott-Burden, C Boulanger, E Weber and F R Bühler
    Molecular Pharmacology August 1990, 38 (2) 244-252;
  • You have access
    Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide.
    J S Woods, C A Calas, L D Aicher, B H Robinson and C Mailer
    Molecular Pharmacology August 1990, 38 (2) 253-260;
  • You have access
    Stimulation of porphyrinogen oxidation by mercuric ion. II. Promotion of oxidation from the interaction of mercuric ion, glutathione, and mitochondria-generated hydrogen peroxide.
    J S Woods, C A Calas and L D Aicher
    Molecular Pharmacology August 1990, 38 (2) 261-266;
  • You have access
    Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
    M Waelbroeck, M Tastenoy, J Camus and J Christophe
    Molecular Pharmacology August 1990, 38 (2) 267-273;
  • You have access
    Pertussis toxin inhibits norepinephrine-stimulated inositol phosphate formation in primary brain cell cultures.
    K M Wilson and K P Minneman
    Molecular Pharmacology August 1990, 38 (2) 274-281;
  • You have access
    Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.
    M D Campbell, S Subramaniam, M I Kotlikoff, J R Williamson and S J Fluharty
    Molecular Pharmacology August 1990, 38 (2) 282-288;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 38, Issue 2
1 Aug 1990
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics